World's Best Scientists 2026 revealed!
Award Badge
Medicine
Spain
2023

D-Index & Metrics

Medicine

D-Index
111
Citations
96848
World Ranking
5220
National Ranking
71

Jose Lopez-Sendon publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Jose Lopez-Sendon sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 671 publications — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Jose Lopez-Sendon D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Jose Lopez-Sendon sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 111 D-Index — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2023 - Research.com Medicine in Spain Leader Award

Overview

Jose Lopez-Sendon is affiliated with Hospital Universitario La Paz in Spain and has made contributions predominantly in the field of Medicine, with a focus on Cardiology and Cardiovascular Medicine. Their research spans an array of related subfields including Surgery, Molecular Biology, Radiology, Nuclear Medicine and Imaging, and Infectious Diseases.

The scientist has published extensively on topics such as Cardiac Imaging and Diagnostics, Coronary Interventions and Diagnostics, COVID-19 Clinical Research Studies, Heart Failure Treatment and Management, Atrial Fibrillation Management and Outcomes, Venous Thromboembolism Diagnosis and Management, and Inflammasome and Immune Disorders.

Jose Lopez-Sendon's work has appeared frequently in several leading publication venues:

  • Circulation
  • Journal of the American College of Cardiology
  • European Heart Journal
  • Journal of the American Heart Association
  • JAMA Cardiology

Notable recent papers include:

  • "Heart failure in COVID-19 patients: prevalence, incidence and prognostic implications," 2020, European Journal of Heart Failure
  • "Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial," 2021, The Lancet Respiratory Medicine
  • "Classification, prevalence, and outcomes of anticancer therapy-induced cardiotoxicity: the CARDIOTOX registry," 2020, European Heart Journal
  • "Association of Sex With Severity of Coronary Artery Disease, Ischemia, and Symptom Burden in Patients With Moderate or Severe Ischemia," 2020, JAMA Cardiology
  • "Survival After Invasive or Conservative Management of Stable Coronary Disease," 2022, Circulation

Frequent co-authors who have collaborated with Jose Lopez-Sendon include:

  • Judith S. Hochman
  • Harmony R. Reynolds
  • David J. Maron
  • Aldo P. Maggioni
  • William E. Boden

Best Publications

  • Apixaban versus Warfarin in Patients with Atrial Fibrillation

    Christopher B. Granger;John H. Alexander;Renato D. Lopes;Elaine M. Hylek

  • Guidelines on the Diagnosis and Management of Acute Pulmonary Embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC)

    Adam Torbicki;Arnaud Perrier;Stavros Konstantinides;Giancarlo Agnelli

  • Universal definition of myocardial infarction.

    Kristian Thygesen;Joseph S. Alpert;Harvey D. White;Allan S. Jaffe

  • Effects of Torcetrapib in Patients at High Risk for Coronary Events

    Philip J. Barter;Mark Caulfield;Mats Eriksson;Scott M Grundy

  • Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.

    Karl Swedberg;John Cleland;Henry Dargie;Helmut Drexler

  • Addition of Clopidogrel to Aspirin and Fibrinolytic Therapy for Myocardial Infarction with ST-Segment Elevation

    Marc S. Sabatine;Christopher P. Cannon;C. Michael Gibson;Jose L. López-Sendón

  • Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies

    Mike A Nalls;Cornelis Blauwendraat;Costanza L Vallerga;Karl Heilbron

  • Initial invasive or conservative strategy for stable coronary disease.

    David J. Maron;Judith S. Hochman;Harmony R. Reynolds;Sripal Bangalore

  • Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

    Adrian F Hernandez;Jennifer B Green;Salim Janmohamed;Ralph B D'Agostino

  • EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population.

    Markku S. Nieminen;Dirk Brutsaert;Kenneth Dickstein;Helmut Drexler

  • Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome

    John H. Jh Alexander;RD D Renato D. Rd Renato D Lopes;Stefan James;Rakhi Kilaru

  • Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial.

    James J Ferguson;Robert M Califf;Elliott M Antman;Marc Cohen

  • Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE)

    Mauro Moscucci;Keith A. A. Fox;Christopher P. Cannon;Werner Klein

  • GUIDELINES FOR PRE-OPERATIVE CARDIAC RISK ASSESSMENT AND PERIOPERATIVE CARDIAC MANAGEMENT IN NON-CARDIAC SURGERY

    Don Poldermans;Jeroen J. Bax;Eric Boersma;Stefan De Hert

  • Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study.

    Marc S. Sabatine;Christopher P. Cannon;C. Michael Gibson;Jose L. López-Sendón

  • Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors

    Stuart J. Connolly;Truman J. Milling;John W. Eikelboom;C. Michael Gibson

  • Guidelines on myocardial revascularization.

    Philippe Kolh;William Wijns;Nicolas Danchin;Carlo Di Mario

  • Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors

    Stuart J. Connolly;Mark Crowther;John W. Eikelboom;C. Michael Gibson

  • Executive summary of the guidelines on the diagnosis and treatment of acute heart failure

    Nieminen Ms;Böhm M;Drexler H

  • Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation

    Marc S. Sabatine;Christopher P. Cannon;C. Michael Gibsonn;Jose L. Lopez-Sendon

Frequent Co-Authors

Andrzej Budaj
Andrzej Budaj Center of Postgraduate Medical Education, Grochowski Hospital
Christopher B. Granger
Christopher B. Granger Duke University
Lars Wallentin
Lars Wallentin Uppsala University
Joel M. Gore
Joel M. Gore University of Massachusetts Chan Medical School
Gilles Montalescot
Gilles Montalescot Baim Institute for Clinical Research
Shaun G. Goodman
Shaun G. Goodman University of Toronto
Keith A.A. Fox
Keith A.A. Fox University of Edinburgh
Renato D. Lopes
Renato D. Lopes Duke University
Eugene Braunwald
Eugene Braunwald Harvard Medical School

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in healthcare but searching for flexible education options, online nursing degrees offer accessible pathways into the field. Many aspiring nurses are exploring cheapest online fnp program choices to become Family Nurse Practitioners (FNP) without incurring heavy student debt.

Additionally, online options such as affordable nursing programs are helping students save while earning respected credentials. Those looking to advance their careers or move into leadership roles may consider pursuing phd in nursing online programs, which enable graduates to teach, conduct research, or lead top healthcare organizations.

If you are a registered nurse looking to further your education, understanding the average cost of rn to bsn programs can help you plan for your next steps. Exploring these related online degrees and career pathways makes it easier to find affordable, flexible healthcare education—and a rewarding profession in medicine.

Best Scientists Citing Jose Lopez-Sendon

Trending Scientists

Recently Published Articles